GLP-1 Treatment in Wisconsin: What It Costs and Who Covers It

A Wisconsin overview of physician-supervised GLP-1 treatment through Astra, including local access context and the cities we cover. Every statistic on this page links to its source.

37.4% of Wisconsin adults had obesity in 2024, per CDC BRFSS 4 — which places Wisconsin in the CDC's highest published reporting band for state-level adult obesity, at or above 35%.

Wisconsin is also one of the few states whose Medicaid program lists an anti-obesity GLP-1 as covered, which makes the details of what is and isn't on the drug list matter more here than a flat yes or no.

Adult obesity rate (2024)
37.4%4
National adult obesity rate
Not published for this area. We do not estimate it.
Adults with obesity (modelled)
Not published for this area. We do not estimate it.
State population
5,960,9755
Uninsured rate
5.3%6
Median household income
$77,4886
Medicaid coverage for weight loss
Wisconsin Medicaid (BadgerCare Plus, via ForwardHealth) covers select anti-obesity agents — Zepbound (tirzepatide) and a product listed as "Foundayo" — subject to mandatory prior authorization for every drug in that class; it does not list Wegovy (semaglutide) anywhere on the Preferred Drug List. A separate "Hypoglycemics, GLP 1" class covers Ozempic, Mounjaro, Trulicity, Victoza, Byetta, and Soliqua as preferred, but every row there carries a Diagnosis Restriction (DR) limiting that pathway to a diabetes diagnosis, not weight-loss use. Coverage is confirmed current as of the 08/01/2026 PDL revision; the historical start date of this policy is unverified — do not assert when Wisconsin first added obesity-drug coverage. TODO: "Foundayo" is an unfamiliar brand/molecule (likely a 2026-era product) — report the name exactly as it appears on the PDL; do not guess its generic name.123

What BadgerCare Plus actually covers

Wisconsin Medicaid (BadgerCare Plus, via ForwardHealth) covers select anti-obesity agents — Zepbound (tirzepatide) and a product listed as "Foundayo" — subject to mandatory prior authorization for every drug in that class. It does not list Wegovy (semaglutide) anywhere on the Preferred Drug List 12.

A separate "Hypoglycemics, GLP 1" class covers Ozempic, Mounjaro, Trulicity, Victoza, Byetta, and Soliqua as preferred, but every row there carries a Diagnosis Restriction (DR) limiting that pathway to a diabetes diagnosis, not weight-loss use 1. Coverage is confirmed current as of the 08/01/2026 PDL revision 13; the historical start date of this policy is unverified, so this page does not assert when Wisconsin first added obesity-drug coverage. "Foundayo" is reported exactly as it appears on the PDL — an unfamiliar brand we are not going to guess a generic name for.

What GLP-1 care costs in Wisconsin today

Astra's price in Wisconsin is the price everywhere else we operate: $68 a month for compounded semaglutide and $118 a month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416, the same at every dose. There is no Wisconsin price list, no regional surcharge, and no local discount.

5.3% of Wisconsinites are uninsured and median household income is $77,488, per ACS 2024 1-year estimates 6. For anyone whose prescription is for Wegovy — the one anti-obesity GLP-1 absent from the state PDL — or who cannot clear the class-wide prior authorization, that flat published price is the practical number.

Clinician supply across Wisconsin

Wisconsin has 175 primary care Health Professional Shortage Area designations covering 2,008,378 people, with 66% of need met — 223 additional primary-care practitioners needed to eliminate all designations — as of December 31, 2025 7. That figure comes from HRSA data as reported by KFF State Health Facts, a secondary aggregator rather than a first-party HRSA citation, because data.hrsa.gov query endpoints returned 403s under this session's constraints. Telehealth is one way around the appointment backlog those designations describe.

Is telehealth prescribing legal in Wisconsin?

The operative authority is the Wisconsin Medical Examining Board (WI DSPS). TODO: Wisconsin-specific telehealth prescribing rules — for example initial-visit and informed-consent requirements for controlled versus non-controlled substances — were not verified this session. The live source and URL need to be confirmed with the Medical Examining Board before this section ships, and this page is not implying the rules were checked.

Availability in Wisconsin

Astra serves patients in all 50 states, including Wisconsin — Madison, Milwaukee, and the rest of the state, with intake and follow-up online and no in-person visit required.

Astra treats patients in Wisconsin through state-licensed physicians.

Wisconsin cities

Madison has its own page with city-level data and local access detail, under the same sourcing rules as this page.

Frequently asked questions

Does Wisconsin Medicaid (BadgerCare Plus) cover GLP-1 medications for weight loss?

Yes, narrowly. Wisconsin’s ForwardHealth Preferred Drug List (revised 08/06/2026, effective 08/01/2026) added a "Weight Management Agents" class covering Zepbound (tirzepatide) and a product listed as Foundayo as preferred drugs — but both require mandatory prior authorization, and Wegovy (semaglutide) does not appear anywhere on the list. Ozempic, Mounjaro, Trulicity, Victoza, Byetta, and Soliqua are preferred under a separate drug class, but only for a diabetes diagnosis, not weight loss.

How much does GLP-1 treatment cost through Astra in Wisconsin?

The same as everywhere Astra operates: $68/month for semaglutide or $118/month for tirzepatide, billed on a 12-month plan ($816 or $1,416 per year). Astra doesn’t set different prices by city or state.

Is Astra cheaper in Wisconsin than other options?

We haven’t verified state-wide self-pay clinic pricing, so we won’t guess at a number here — check the Madison city page for sourced local pricing where available. What we can say precisely: Astra’s $68–$118/month rate doesn’t change by ZIP code, and BadgerCare Plus’s own coverage requires prior authorization and excludes Wegovy outright, which leaves many Wisconsin residents paying cash regardless of provider.

Is Astra available in Madison and across Wisconsin?

Yes. Astra is licensed to provide telehealth GLP-1 care in all 50 states, including every city and county in Wisconsin.

What is Wisconsin’s adult obesity rate?

37.4% of Wisconsin adults were classified as having obesity in 2024, per CDC BRFSS data — placing the state in the CDC’s highest reporting band (≥35%) for state-level adult obesity prevalence.

Sources

  1. ForwardHealth Preferred Drug List Quick Reference (rev. 08/06/2026, eff. 08/01/2026) — PDF, pp. 9 & 14 — https://www.forwardhealth.wi.gov/WIPortal/content/provider/medicaid/pharmacy/pdl/pdfs/quickref08062026.pdf.spage
  2. ForwardHealth Pharmacy Resources page (links current/archived PDLs) — https://www.forwardhealth.wi.gov/WIPortal/content/provider/medicaid/pharmacy/resources.htm.spage
  3. KFF: Medicaid Coverage of and Spending on GLP-1s (Jan 2026 brief) — https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
  4. CDC BRFSS — Nutrition, Physical Activity, and Obesity dataset (Wisconsin, 2024 survey year) — https://data.cdc.gov/Nutrition-Physical-Activity-and-Obesity/Nutrition-Physical-Activity-and-Obesity-Behaviora/hn4x-zwk7
  5. U.S. Census Bureau, Population Estimates Program, Vintage 2024 state totals — https://www2.census.gov/programs-surveys/popest/datasets/2020-2024/state/totals/NST-EST2024-ALLDATA.csv
  6. Census Reporter API — ACS 2024 1-year, Wisconsin (B27001, B19013) — https://api.censusreporter.org/1.0/data/show/latest?table_ids=B27001,B19013&geo_ids=04000US55
  7. KFF State Health Facts — Primary Care HPSAs (HRSA-sourced), Wisconsin — https://www.kff.org/other/state-indicator/primary-care-health-professional-shortage-areas-hpsas/

Last reviewed:

Educational information, not medical advice. Treatment requires evaluation by a licensed physician.